Replimune Group shares fell 28% on heavy volume with no news, despite a promising July 2025 PDUFA date for RP1 in advanced ...

BioVaxys Technology Corp. ( BioVaxys) and Sona Nanotech Inc. ( Sona) have entered a Research Agreement to develop new cancer ...

Collaboration supports manufacture of the OPTF01 product to Drive Next-Generation Chimeric Antigen Receptor T Cell (CAR-T) Development INDIANAPOLIS and EHIME, Japan, May 5, 2025 /PRNewswire/ -- ...

ALTON - Siteman Cancer Center, Alton Memorial Hospital and Senior Services Plus (SSP) are once again hosting a Bingo Lunch ...

Precision BioSciences, Inc.’s DTIL share price has dipped by 9.90%, which has investors questioning if this is right time to ...

A new report reveals disparities in chimeric antigen receptor (CAR) T-cell therapy delivery across Europe, with healthcare system utilisation rates of the therapy as low as 11% for eligible patients.

Once prostate cancer no longer responds to hormonal therapy, the cancer is called castration-resistant. Find out which ...

A free men’s health screening event next Saturday will provide Madison-area men with vital health information—and a free ...

PDS Biotechnology Corporation (NASDAQ: PDSB) Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation ...

WXII 12 News will hold a Community Blood Drive on Thursday, May 29, at College Park Baptist Church Gym located at 1701 Polo ...

Qiagen has a relatively well-diversified portfolio across four segments. Find out my recommendation on QGEN stock here.